Compare UPWK & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPWK | GRDN |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3400 |
| Industry | EDP Services | Retail-Drug Stores and Proprietary Stores |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2018 | N/A |
| Metric | UPWK | GRDN |
|---|---|---|
| Price | $13.18 | $33.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | $22.33 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 4.7M | 178.0K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $787,784,000.00 | N/A |
| Revenue This Year | $9.16 | $19.50 |
| Revenue Next Year | $13.32 | N/A |
| P/E Ratio | ★ $15.84 | $117.77 |
| Revenue Growth | ★ 2.40 | N/A |
| 52 Week Low | $11.13 | $17.78 |
| 52 Week High | $22.84 | $37.43 |
| Indicator | UPWK | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 52.10 |
| Support Level | $12.73 | $31.82 |
| Resistance Level | $14.19 | $33.04 |
| Average True Range (ATR) | 1.17 | 1.43 |
| MACD | -0.47 | -0.07 |
| Stochastic Oscillator | 6.65 | 52.93 |
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.